跳至主要内容
临床试验/IRCT20170513033941N31
IRCT20170513033941N31已完成3 期

Clinical trial of the effect of melatonin supplementation compared with the placebo on metabolic status and gene expression related to inflammation, insulin and lipid in diabetic hemodialysis patients

Kashan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • diabetic hemodialysis patients
  • Individuals aged 18 to 80 years old

排除标准

  • Patients with infectious, inflammatory and malignant diseases
  • those taking melatonin supplements, antioxidant and/or anti-inflammatory supplements within 3 months prior to enrollment in the study
  • the night shift workers
  • subjects taking immunosuppressive and antibiotics medications
  • unwillingness to cooperate

研究者

相似试验